These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5083175)

  • 1. Psychobiological and pharmacological studies of manic-depressive illness.
    Bunney WE; Gershon ES; Murphy DL; Goodwin FK
    J Psychiatr Res; 1972 Sep; 9(3):207-26. PubMed ID: 5083175
    [No Abstract]   [Full Text] [Related]  

  • 2. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 3. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.
    Bunney WE; Goodwin FK; Murphy DL; House KM; Gordon EK
    Arch Gen Psychiatry; 1972 Sep; 27(3):304-9. PubMed ID: 4340658
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania.
    Bunney WE; Brodie HK; Murphy DL; Goodwin FK
    Am J Psychiatry; 1971 Jan; 127(7):872-81. PubMed ID: 4924778
    [No Abstract]   [Full Text] [Related]  

  • 5. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.
    Murphy DL; Brodie HK; Goodwin FK; Bunney WE
    Nature; 1971 Jan; 229(5280):135-6. PubMed ID: 4321339
    [No Abstract]   [Full Text] [Related]  

  • 6. Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.
    Brodie HK; Murphy DL; Goodwin FK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):218-24. PubMed ID: 5554938
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and pharmacological investigations of the psychobiology of the affective disorders.
    Murphy DL; Goodwin FK; Bunney WE
    Int Pharmacopsychiatry; 1971; 6(3):137-46. PubMed ID: 4150691
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of aminazine on the excretion of adrenaline noradrenaline, dopamine and dopa in healthy subjects and in the manic phase of manic-depressive psychosis].
    Matlina ESh; Osipova MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):128-31. PubMed ID: 5448719
    [No Abstract]   [Full Text] [Related]  

  • 10. Precursors of melanin in the blood and urine in malignant melanoma.
    Hinterberger H; Freedman A; Bartholomew RJ
    Clin Chim Acta; 1972 Jul; 39(2):395-400. PubMed ID: 5043774
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemistry of depression].
    Matussek N
    J Neural Transm; 1972; 33(3):223-34. PubMed ID: 4565920
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
    Geissbuhler F; Eisenring JJ; Friedli P; Bartholini G; Tissot R
    Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of affective states and psychoactive drugs on verbal learning and memory.
    Henry GM; Weingartner H; Murphy DL
    Am J Psychiatry; 1973 Sep; 130(9):966-71. PubMed ID: 4727774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa: alterations in behavior.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):383-96. PubMed ID: 4930867
    [No Abstract]   [Full Text] [Related]  

  • 16. Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients.
    Bond PA; Jenner FA; Sampson GA
    Psychol Med; 1972 Feb; 2(1):81-5. PubMed ID: 5012606
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M; Tanabe H; Yano Y; Nakao K
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract]   [Full Text] [Related]  

  • 19. Catecholamine metabolism of manic-depressive illness.
    Takahashi R; Nagao Y; Tsuchiya K; Takamizawa M; Kobayashi T; Toru M; Kobayashi K; Kariya T
    J Psychiatr Res; 1968 Dec; 6(3):185-99. PubMed ID: 5731854
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.